Daiichi Sankyo Company, Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DSKYF research report →
Companywww.daiichisankyo.com
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic.
- CEO
- Hiroyuki Okuzawa
- IPO
- 2008
- Employees
- 18,726
- HQ
- Tokyo, JP
Price Chart
Valuation
- Market Cap
- $29.41B
- P/E
- 18.81
- P/S
- 2.28
- P/B
- 2.94
- EV/EBITDA
- 14.72
- Div Yield
- 2.93%
Profitability
- Gross Margin
- 68.49%
- Op Margin
- 9.80%
- Net Margin
- 12.24%
- ROE
- 15.74%
- ROIC
- 6.58%
Growth & Income
- Revenue
- $2.14T · 13.26%
- Net Income
- $261.51B · -11.58%
- EPS
- $140.61 · -9.84%
- Op Income
- $208.62B
- FCF YoY
- 61.93%
Performance & Tape
- 52W High
- $29.15
- 52W Low
- $15.16
- 50D MA
- $17.51
- 200D MA
- $21.29
- Beta
- -0.17
- Avg Volume
- 13.24K
Get TickerSpark's AI analysis on DSKYF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DSKYF Coverage
We haven't published any research on DSKYF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DSKYF Report →